Caldolor(R) (Ibuprofen) Injection Demonstrates Significant Fever Reduction In Hospitalized Burn Patients
Cumberland Pharmaceuticals Inc. ( CPIX) announced positive new top-line results from a study evaluating the safety and efficacy of Caldolor (ibuprofen) Injection in treating fever in hospitalized burn patients. Statistical significance was achieved for the primary endpoint of reducing fever in burn patients over the first 24 hours of treatment.
Posted by SkinDoc on Tuesday, November 24, 2009, at 7:40 am. Filed under Skin Care News. Tagged Cpix, Cumberland, Efficacy, Endpoint, Ibuprofen, Pharmaceuticals Inc, Reducing Fever, Statistical Significance.
Both comments and trackbacks are currently closed.
